Why pharmacovigilance is moving from workflow automation to AI-assisted decision intelligence

Neutral

AI Analysis

Summary

Article discusses industry trends in pharmacovigilance showing 48% of life sciences executives expect digital technologies and data analytics to substantially impact their organizations, with movement toward AI-assisted decision intelligence.

Importance:2/10

Sentiment:

0.00

pharmacovigilanceAIdigital transformationsafety dataworkflow automation

Related Companies

$GBCYD $IBO $TRAX $RTSL

Read the original article

Published by Drug Discovery & Development on August 7, 2026 9:49 PM

Read Original